Should I buy Universal Health Services (UHS) stock or is it too late?

Universal Health Services · Health Care · price $173

See the full Universal Health Services (UHS) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Morgan Stanley — 69% of its targets hit on this sector (825 calls tested). It aims for $191 (+11 %), call made on July 30, 2026, maturing on July 30, 2027 (29 d ago).

The 7 reliable analysts $189+9.5 %

The 3 other firms $194+12 %

How to read it: the 7 reliable firms are not filtered by optimism — 4 aim above the price, 3 below, hence their $189 median. “The 3 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Universal Health Services

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
B of A Securities	80 %	+15.9 %	10	$185 +7%
JP Morgan	60 %	+15.5 %	5	$195 +13%
Barclays	60 %	+10.9 %	20	$168 -3%
UBS	54 %	+3.7 %	13	$310 +80%
Wells Fargo	58 %	+1.0 %	12	$166 -4%
Goldman Sachs	50 %	-2.6 %	12	$190 +10%
Cantor Fitzgerald	44 %	-9.1 %	9	$194 +12%
Credit Suisse	88 %	+27.2 %	17	—

In short — Should you invest in Universal Health Services? Is it too late, still worth it? Analysts are split (30% buy, median target $190, i.e. +10%), and the most reliable on UHS targets even higher. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $190, i.e. +10% from the current price ($173).
The most reliable firm on UHS, TD Cowen (67% hit rate, 3 scored calls), targets $197 (call made on June 22, 2026, maturing on June 22, 2027) (+14%) in its most recent call, and $245 (call made on January 7, 2026, maturing on January 7, 2027) (+42%) in the one coming due soonest.
Reasonable valuation (P/E ~7) relative to its sector.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 10 ratings, 7 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on UHS

Median target $190 (+10%) · 10 ratings · Hold consensus

Strong Buy00%

Buy330%

Hold770%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Universal Health Services now?

We won't decide for you. The facts: 30% of analysts rate it a buy, median target $190 (+10%), and TD Cowen (most reliable on UHS, 67%) targets $197. Weigh that against valuation (P/E ~7). This is not personalized advice.

Is it too late to invest in Universal Health Services?

Not according to analysts: the median target ($190) is still +10% above the current price ($173) (most reliable on UHS: TD Cowen, 67%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Universal Health Services still worth investing in?

It depends on the gap between the price ($173) and its estimated value: analysts target $190 on median (+10%), with 30% buys (most reliable on UHS: TD Cowen, 67%). Cross-check with their real reliability on UHS and the cautions above. Information, not advice.

What's the main risk in buying UHS?

The consensus is not unanimous: of 10 ratings, 7 are neutral.

→ Go deeper: the full Universal Health Services profile (consensus, analyst reliability, price target, performance).